What Is Keshan Disease
Keshan disease is an endemic cardiomyopathy caused primarily by selenium deficiency, combined with a coxsackievirus infection. It was first identified in the Keshan county of Heilongjiang province in China in 1935. The condition leads to myocardial necrosis, cardiac enlargement, and potential heart failure, particularly affecting children and women of childbearing age in selenium-poor regions.
The disease is classified as a nutritional deficiency disorder by the World Health Organization. It occurs in specific geographic zones where the soil and local food supply contain very low levels of selenium. The primary pathological mechanism involves oxidative stress in heart tissue, which is normally protected by selenium-dependent antioxidant enzymes like glutathione peroxidase.
Epidemiology and Regional Distribution
Geographic Hotspots
The disease is concentrated in a belt of selenium-deficient soils stretching from northeast to southwest China. Key affected provinces include Heilongjiang, Jilin, Liaoning, Inner Mongolia, Gansu, and Sichuan. These regions have soil selenium levels below 0.1 mg/kg, which directly translates to low selenium content in locally grown crops and grains.
Outside China, similar selenium-deficiency cardiomyopathy patterns have been observed in parts of Europe, including Finland and Poland, before the implementation of mandatory selenium fertilization programs. The disease's distribution strictly correlates with low dietary selenium intake, typically below 17 micrograms per day, compared to the recommended intake of 55 to 70 micrograms for adults.
Risk Demographics
Children aged 2 to 10 and pregnant women are the highest-risk groups due to increased metabolic demands and rapid growth. The acute form of the disease can cause sudden cardiac death, while the chronic form leads to an enlarged heart and reduced pumping efficiency. Seasonal outbreaks often occur in late winter and early spring when dietary selenium stores are depleted.
Prevention, Supplementation, and Public Health Response
Selenium Supplementation Programs
China's national selenium supplementation program, initiated in the 1970s, successfully reduced Keshan disease incidence by providing sodium selenite tablets to at-risk populations. The program demonstrated that a daily dose of 50 to 100 micrograms of selenium effectively prevents the disease. This intervention is documented by public health authorities as a major success in nutritional epidemiology.
Global selenium fortification strategies vary, with countries like Finland mandating selenium addition to fertilizers since 1984, which raised population blood selenium levels to optimal ranges. The U.S. National Institutes of Health sets the tolerable upper intake level for selenium at 400 micrograms per day for adults to avoid toxicity. The American Heart Association notes that maintaining adequate selenium levels supports overall cardiovascular health, though supplementation is not a standard treatment for non-deficient populations.
Current Research and Monitoring
Ongoing research focuses on the interaction between selenium status and viral virulence, particularly how selenoproteins influence the replication of coxsackieviruses. The National Institutes of Health Office of Dietary Supplements provides current fact sheets on selenium, referencing studies that link low selenium status to increased oxidative damage in viral infections. Monitoring soil selenium levels remains critical for predicting and preventing future outbreaks in vulnerable agricultural regions.